Entheon Biomedical Corp. Announces Acquisition of HaluGen Life Sciences Inc.
Entheon Biomedical Corp. Announces Acquisition of HaluGen Life Sciences Inc. Vancouver, British Columbia--(Newsfile Corp. - January 14, 2021) - Entheon Biomedical Corp. (CSE: ENBI) (FSE: 1XU1) (" Entheon" or the " Company") is pleased to announce that the Company completed its acquisition of HaluGen Life Sciences Inc. (" HaluGen"), a biotech company in the business of developing and commercializing a pre-screening test to identify genetic markers predictive of an individual's reaction to hallucinogenic drugs. The Company acquired 100% of the issued and outstanding common shares in the capita...
Source: finanznachrichten.de